Table 2 Results from two-way ANOVA testing the variables gene (WT and LRRK2-KO rats) and drug (vehicle and PFE360).
From: Knocking out the LRRK2 gene increases sensitivity to wavelength information in rats
Two-way ANOVA | ||||
|---|---|---|---|---|
F value | Adjusted p value (if p < 0.05) | |||
Amplitude of peaks in the superior colliculus | ||||
P1 | Gene | F(1,27) | 6.5 | 0.019 |
Drug | F(1,273) | 0.0070 | ||
N1 | Gene | F(1,27) | 14 | 0.0012 |
Drug | F(1,273) | 0.065 | ||
P2 | Gene | F(1,27) | 1.7 | |
Drug | F(1,273) | 0.87 | ||
interaction | F(1,273) | 13 | 0.00064 | |
N2 | Gene | F(1,27) | 0.96 | |
Drug | F(1,273) | 20 | 0.00021 | |
P3 | Gene | F(1,27) | 0.66 | |
Drug | F(1,273) | 5.5 | 0.021 | |
Latency of peaks in the superior colliculus | ||||
P1 | Gene | F(1,27) | 8.3 | 0.009 |
Drug | F(1,273) | 137 | 0.00021 | |
N1 | Gene | F(1,27) | 3.2 | |
Drug | F(1,273) | 84 | 0.00021 | |
P2 | Gene | F(1,27) | 19 | 0.00036 |
Drug | F(1,273) | 14 | 0.00036 | |
interaction | F(1,273) | 3.9 | 0.049 | |
N2 | Gene | F(1,27) | 7.3 | 0.013 |
Drug | F(1,273) | 12 | 0.00076 | |
P3 | Gene | F(1,27) | 3.1 | |
Drug | F(1,273) | 25 | 0.00021 | |
